Abstract:Aberrant alternative splicing events play critical roles in carcinogenesis and progression of many cancers, while sparse studies regarding to alternative splicing are available for clear cell renal cell carcinoma (ccRCC). We identified that alternative splicing of coiled-coil domain containing 50 (CCDC50) was dysregulated in ccRCC, whereas the clinical significance of this splicing event and its splicing regulation mechanisms were still elusive.Bioinformatic algorithm was utilized to identify significant exon skipping events in ccRCC via exon sequencing data from The Cancer Genome Atlas. Semi-quantitative real-time polymerase chain reaction and western blot were used to validate the aberrant expression of different transcripts in renal cancer tissues, cell lines and corresponding noncancerous controls. Short hairpin RNA targeting CCDC50 and overexpressing plasmids for each transcript were introduced into ccRCC cell lines, followed by a series of in vitro and in vivo functional experiments. Moreover, a panel of splicing factors were identified and their roles on splicing regulation of CCDC50 precursor mRNA (pre-mRNA) were studied. Furthermore, RNAseq data were analyzed to elucidate downstream molecules of CCDC50. Two-way analysis of variance and unpaired Student t test were used in statistical analysis.Pre-mRNA of CCDC50 generated two transcripts, full-length transcript (CCDC50-FL) and truncated transcript (CCDC50-S) with exon 6 skipped. CCDC50-S was overexpressed in ccRCC tissues and cell lines compared to noncancerous counterparts, but CCDC50-FL was only detected in noncancerous tissues and normal renal epithelial cells. Higher percent spliced-in index was associated with better survival in ccRCC patients. In vitro and in vivo functional experiments indicated that CCDC50-S transcript promoted the proliferation, migration, invasion and tumorigenesis of ccRCC, while CCDC50-FL exerted opposite tumor suppressive functions. Besides, we identified that heterogeneous nuclear ribonucleoprotein A1 (HnRNP A1) could promote the skipping of exon 6, which resulted in higher portion of CCDC50-S and oncogenic transformation. Moreover, zinc finger protein 395 (ZNF395) was identified as a downstream protein of CCDC50-S, and the interaction initiated oncogenic pathways which were involved in ccRCC progression.Aberrant alternative splicing of CCDC50 is regulated by HnRNP A1 in ccRCC. This splicing event contributes to cancer progression through the downstream pathway involving ZNF395.

Human DBR1 Modulates the Recycling of Snrnps to Affect Alternative RNA Splicing and Contributes to the Suppression of Cancer Development

Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation

SRSF1 Prevents DNA Damage and Promotes Tumorigenesis Through Regulation of DBF4B Pre-mRNA Splicing.

SR Splicing Factors Promote Cancer Via Multiple Regulatory Mechanisms.

Abstract 3080: DBP-RB, a Novel RNA-binding Protein Promotes Microrna Processing in the DNA Damage Response.

RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing

The RNA-binding protein HuR in human cancer: A friend or foe?

HNRNPA1-mediated 3′ UTR Length Changes of HN1 Contributes to Cancer- and Senescence-Associated Phenotypes

Role of RNA binding proteins of the Drosophila behavior and human splicing (DBHS) family in health and cancer

RNA splicing dysregulation and the hallmarks of cancer

SUMO1 Modification of KHSRP Regulates Tumorigenesis by Preventing the TL-G-Rich Mirna Biogenesis

Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing

RNA-binding Protein RBM28 Can Translocate from the Nucleolus to the Nucleoplasm to Inhibit the Transcriptional Activity of P53.

RETRACTED ARTICLE: HnRNP A1 - Mediated Alternative Splicing of CCDC50 Contributes to Cancer Progression of Clear Cell Renal Cell Carcinoma Via ZNF395

Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway

RNA Binding Motif Protein 10 Suppresses Lung Cancer Progression by Controlling Alternative Splicing of Eukaryotic Translation Initiation Factor 4H

Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma.

RBM10 regulates the tumorigenic potential of human cancer cells by modulating PPM1B and YBX1 activities

Role of Human Noncoding Rnas in the Control of Tumorigenesis

Dependency Of Prostate Cancer On Hnrnpl And Its Associated Rnas